Biogen invests $35 mil. in Genovo and University of Pennsylvania gene delivery research.
Executive Summary
BIOGEN INVESTING $35 MIL. IN GENOVO GENE AND VECTOR RESEARCH being conducted by Genovo founder and consultant James Wilson, MD/PhD, at the University of Pennsylvania Institute for Human Gene Therapy. Biogen will receive a "significant" minority equity stake in Genovo and licensing rights to certain vectors to be developed by the start-up for liver and lung diseases.